Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - Allogene Therapeutics Inc. (ALLO)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
ALLO Insider Trading Transactions for Allogene Therapeutics  Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-10-15
Purchase(A)
2019-02-13
5:10 pm
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director
194,445 $18 $3,500,010 1,691,781
(Indirect)
View
2018-10-15
Purchase
2018-10-17
5:32 pm
Allogene Therapeutics Inc. ALLO WITTE OWEN N.
Director
15,000 $18 $270,000 236,182
(Direct)
View
2018-10-15
Purchase
2018-10-17
5:32 pm
Allogene Therapeutics Inc. ALLO Humer Franz B
Director
30,000 $18 $540,000 104,870
(Direct)
View
2018-10-15
Purchase
2018-10-17
5:30 pm
Allogene Therapeutics Inc. ALLO Chang David D
CEO
40,000 $18 $720,000 1,995,625
(Indirect
Direct)
View
2018-10-15
Purchase
2018-10-17
5:29 pm
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director, 10% Owner
35,000 $18 $630,000 5,989,352
(Indirect
Direct)
View
2018-10-15
Purchase
2018-10-17
5:17 pm
Allogene Therapeutics Inc. ALLO PFIZER INC
10% Owner
55,556 $18 $1,000,008 22,032,040
(Direct)
View
2018-10-15
Purchase
2018-10-17
5:10 pm
Allogene Therapeutics Inc. ALLO TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
10% Owner
675,000 $18 $12,150,000 23,135,060
(Indirect)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-03-13
Option Award
2019-03-15
5:22 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
37,050 $0 83,500
(Direct)
View
2019-03-13
Option Award
2019-03-15
5:22 pm
N/A
2029-03-12
Allogene Therapeutics Inc. ALLO MOORE ALISON
CTO
83,500 $26.89 83,500
(Direct)
View
2019-03-13
Option Award
2019-03-15
5:21 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO SCHMIDT ERIC THOMAS
CFO
49,400 $0 1,464,750
(Direct)
View
2019-03-13
Option Award
2019-03-15
5:21 pm
N/A
2029-03-12
Allogene Therapeutics Inc. ALLO SCHMIDT ERIC THOMAS
CFO
83,500 $26.89 1,464,750
(Direct)
View
2019-03-13
Option Award
2019-03-15
5:20 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director
115,333 $0 5,989,352
(Direct)
View
2019-03-13
Option Award
2019-03-15
5:20 pm
N/A
2029-03-12
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director
195,133 $26.89 5,989,352
(Direct)
View
2019-03-13
Option Award
2019-03-15
5:19 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
173,000 $0 2,168,625
(Direct)
View
2019-03-13
Option Award
2019-03-15
5:19 pm
N/A
2029-03-12
Allogene Therapeutics Inc. ALLO Chang David D
CEO
292,700 $26.89 2,168,625
(Direct)
View
2018-10-15
Other
2018-10-17
5:33 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO MESSEMER DEBORAH M.
Director
6,535 $0 6,535
(Indirect)
View
2018-10-15
Conversion
2018-10-17
5:32 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO WITTE OWEN N.
Director
37,432 $0 236,182
(Direct)
View
2018-10-15
Conversion
2018-10-17
5:32 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO WITTE OWEN N.
Director
7,130 $0 236,182
(Direct)
View
2018-10-15
Conversion
2018-10-17
5:32 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Humer Franz B
Director
74,870 $0 104,870
(Direct)
View
2018-10-15
Conversion
2018-10-17
5:32 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Humer Franz B
Director
14,261 $0 104,870
(Direct)
View
2018-10-15
Conversion
2018-10-17
5:31 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
18,716 $0 1,390,651
(Direct)
View
2018-10-15
Conversion
2018-10-17
5:31 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Kazam Joshua A
Director
3,565 $0 1,390,651
(Direct)
View
2018-10-15
Conversion
2018-10-17
5:30 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
29,946 $0 1,995,625
(Indirect)
View
2018-10-15
Conversion
2018-10-17
5:30 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Chang David D
CEO
5,704 $0 1,995,625
(Indirect)
View
2018-10-15
Conversion
2018-10-17
5:29 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director, 10% Owner
142,248 $0 5,989,352
(Indirect)
View
2018-10-15
Conversion
2018-10-17
5:29 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director, 10% Owner
5,989,352 $0 5,989,352
(Indirect)
View
2018-10-15
Conversion
2018-10-17
5:29 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director, 10% Owner
1,497,336 $0 5,989,352
(Indirect)
View
2018-10-15
Conversion
2018-10-17
5:29 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director, 10% Owner
27,095 $0 5,989,352
(Indirect)
View
2018-10-15
Conversion
2018-10-17
5:29 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director, 10% Owner
1,140,829 $0 5,989,352
(Indirect)
View
2018-10-15
Conversion
2018-10-17
5:29 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO Belldegrun Arie
Director, 10% Owner
285,207 $0 5,989,352
(Indirect)
View
2018-10-15
Conversion
2018-10-17
5:17 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO PFIZER INC
10% Owner
21,976,484 $0 22,032,040
(Direct)
View
2018-10-15
Conversion
2018-10-17
5:17 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO PFIZER INC
10% Owner
4,185,997 $0 22,032,040
(Direct)
View
2018-10-15
Conversion
2018-10-17
5:10 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
10% Owner
22,460,060 $0 23,135,060
(Indirect)
View
2018-10-15
Conversion
2018-10-17
5:10 pm
N/A
N/A
Allogene Therapeutics Inc. ALLO TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
10% Owner
4,278,107 $0 23,135,060
(Indirect)
View